Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ · Healthcare
Rigel Pharmaceuticals, Inc. Shareholder Equity 2016–2025
Rigel Pharmaceuticals, Inc. annual shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Rigel Pharmaceuticals, Inc. shareholder equity as of December 31, 2025: 391.5M, a 11806.33% increase year-over-year.
- Rigel Pharmaceuticals, Inc. shareholder equity for 2025 were 391.5M, a 11806.33% increase from 2024.
- Rigel Pharmaceuticals, Inc. shareholder equity for 2024 were 3.3M, a 111.48% decrease from 2023.
- Rigel Pharmaceuticals, Inc. shareholder equity for 2023 were -28.6M, a 110.37% increase from 2022.
- Rigel Pharmaceuticals, Inc. shareholder equity for 2022 were -13.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Rigel Pharmaceuticals, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $391 |
| 2024 | $3 |
| 2023 | $-29 |
| 2022 | $-14 |
| 2021 | $30 |
| 2020 | $34 |
| 2019 | $54 |
| 2018 | $110 |
| 2017 | $101 |
| 2016 | $55 |
Rigel Pharmaceuticals, Inc. Shareholder Equity — FAQ
Rigel Pharmaceuticals, Inc. (RIGL) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RIGL's shareholder equity history?
The chart and table above show Rigel Pharmaceuticals, Inc.'s shareholder equity by year and by quarter, including the growth rate.